TOBRAMYCIN INJECTION SOLUTION Canadá - inglês - Health Canada

tobramycin injection solution

fresenius kabi canada ltd - tobramycin (tobramycin sulfate) - solution - 10mg - tobramycin (tobramycin sulfate) 10mg - aminoglycosides

TOBRAMYCIN INJECTION SOLUTION Canadá - inglês - Health Canada

tobramycin injection solution

fresenius kabi canada ltd - tobramycin (tobramycin sulfate) - solution - 40mg - tobramycin (tobramycin sulfate) 40mg - aminoglycosides

Tobramycin Viatris Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

tobramycin viatris

viatris limited - tobramycin 80mg - solution for injection - 80 mg/2ml - active: tobramycin 80mg excipient: disodium edetate sodium bisulfate sodium hydroxide sulfuric acid water for injection - tobramycin is indicated for the treatment of serious bacterial infections caused by susceptible strains of the designated microorganisms in the diseases listed below: - septicaemia in the neonate, child, and adult caused by p aeruginosa, e coli, and klebsiella sp - lower respiratory tract infections caused by p aeruginosa, klebsiella sp, enterobacter sp, serratia sp, e coli, and s aureus (penicillinase and non-penicillinase-producing strains) - serious central-nervous-system infections (meningitis) caused by susceptible organisms - intra-abdominal infections, including peritonitis, caused by e coli, klebsiella sp, and enterobacter sp - skin, bone, and skin-structure infections (including burns) caused by p aeruginosa, proteus sp, e coli, klebsiella sp, enterobacter sp, and s aureus - complicated and recurrent urinary tract infections caused by p aeruginosa, proteus sp (indole-positive and indole-negative), e coli, klebsiella sp, enterobacter sp, serratia sp, s aureus, providencia sp, and citrobacter sp.

Tobramycin-mp Ampullen 80 mg Alemanha - alemão - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

tobramycin-mp ampullen 80 mg

infectopharm arzneimittel und consilium gmbh (3291423) - tobramycin-2.5-sulfat - lösung zur injektion, infusion und inhalation - tobramycin-2.5-sulfat (10659) 122 milligramm

TOBRAMYCIN INHALATION SOLUTION USP Canadá - francês - Health Canada

tobramycin inhalation solution usp

laboratoire riva inc. - tobramycine (sulfate de tobramycine) - solution - 300mg - tobramycine (sulfate de tobramycine) 300mg - aminoglycosides

TOBRAMYCIN solution Estados Unidos - inglês - NLM (National Library of Medicine)

tobramycin solution

medsource pharmaceuticals - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobramycin ophthalmic solution usp, 0.3% is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobramycin ophthalmic solution usp, 0.3%. clinical studies have shown tobramycin to be safe and effective for use in children. tobramycin ophthalmic solution usp, 0.3% is contraindicated in patients with known hypersensitivity to any of its components.

TOBRAMYCIN solution Estados Unidos - inglês - NLM (National Library of Medicine)

tobramycin solution

proficient rx lp - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobramycin ophthalmic solution usp, 0.3% is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobramycin ophthalmic solution usp, 0.3%. clinical studies have shown tobramycin to be safe and effective for use in children. tobramycin ophthalmic solution usp, 0.3% is contraindicated in patients with known hypersensitivity to any of its components.

TOBRAMYCIN CH tobramycin 300 mg/5 mL inhalation solution ampoule Austrália - inglês - Department of Health (Therapeutic Goods Administration)

tobramycin ch tobramycin 300 mg/5 ml inhalation solution ampoule

juno pharmaceuticals pty ltd - tobramycin, quantity: 60 mg/ml - inhalation, conventional - excipient ingredients: sulfuric acid; sodium hydroxide; water for injections; sodium chloride - tobramycin solution for inhalation is indicated for the management of cystic fibrosis patients with p. aeruginosa infections.,safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with fev1 ? 25 % or ? 80 % predicted at screening, or patients colonized with burkholderia cepacia (see clinical trials).

Tobramycine Steri-Neb 300 mg/5 ml, verneveloplossing Holanda - holandês - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

tobramycine steri-neb 300 mg/5 ml, verneveloplossing

medcor pharmaceuticals b.v. artemisweg 232 8239 de lelystad - tobramycine 300 mg/stuk - verneveloplossing - natriumchloride ; natriumhydroxide (e 524) ; water voor injectie ; zwavelzuur (e 513) - tobramycin

JAMP-TOBRAMYCIN Solution Canadá - francês - Health Canada

jamp-tobramycin solution

jamp pharma corporation - tobramycine (sulfate de tobramycine) - solution - 40mg - tobramycine (sulfate de tobramycine) 40mg - aminoglycosides